FCCC    PyIgClassify2: Classification of Antibody CDR Conformations     Dunbrack Lab
 

CDRs for query 6ZWK


#CDRs = 4; #Clusters = 4.
ChainGenePDB SpeciesFrame GermlineFrame %CDR GermlineCDR %CDRLengthClusterDistance(°)SequenceRamachandran
AheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH84.6H113H1-13-18AASGLTFSRYAMGBBBLBBAAABBBB
AheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH40.0H210H2-10-27VITASGRTTLBBBAALABBB
AheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H318H3-18-*-1AADYgtsrYTRRQSEYEY 
AheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H48H4-8-16RDNAKNTVBBAAALBB
BheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH84.6H113H1-13-18AASGLTFSRYAMGBBBLBBAAABBBB
BheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH40.0H210H2-10-27VITASGRTTLBBBAALABBB
BheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H318H3-18-*-1AADYgtsrYTRRQSEYEY 
BheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H48H4-8-16RDNAKNTVBBAAALBB
CheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH84.6H113H1-13-18AASGLTFSRYAMGBBBLBBAAABBBB
CheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH40.0H210H2-10-27VITASGRTTLBBBAALABBB
CheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H318H3-18-*-1AADYgtsrYTRRQSEYEY 
CheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H48H4-8-18RDNAKNTVBBAAALBB
DheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH84.6H113H1-13-18AASGLTFSRYAMGBBBLBBAAABBBB
DheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH40.0H210H2-10-26VITASGRTTLBBBAALABBB
DheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H318H3-18-*-1AADYgtsrYTRRQSEYEY 
DheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H48H4-8-17RDNAKNTVBBAAALBB
EheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH84.6H113H1-13-17AASGLTFSRYAMGBBBLBBAAABBBB
EheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH40.0H210H2-10-27VITASGRTTLBBBAALABBB
EheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H318H3-18-*-1AADYgtsrYTRRQSEYEY 
EheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H48H4-8-17RDNAKNTVBBAAALBB
FheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH84.6H113H1-13-19AASGLTFSRYAMGBBBLBBAAABBBB
FheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH40.0H210H2-10-27VITASGRTTLBBBAALABBB
FheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H318H3-18-*-1AADYgtsrYTRRQSEYEY 
FheavyVicugna.pacosAl_IGHV3-3*01_VHH93.2Al_IGHV3-3*01_VHH100.0H48H4-8-15RDNAKNTVBBAAALBB
 

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022


Contact Us | ProtCID | ProtCAD | Dunbrack Laboratory | Fox Chase Cancer Center